title: Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial.
authors.forename: Andrés J M
authors.initials: AJ
authors.lastname: Ferreri
authors.forename: Silvia
authors.initials: S
authors.lastname: Govi
authors.forename: Markus
authors.initials: M
authors.lastname: Raderer
authors.forename: Antonino
authors.initials: A
authors.lastname: Mulè
authors.forename: Alessandro
authors.initials: A
authors.lastname: Andriani
authors.forename: Daniele
authors.initials: D
authors.lastname: Caracciolo
authors.forename: Liliana
authors.initials: L
authors.lastname: Devizzi
authors.forename: Fiorella
authors.initials: F
authors.lastname: Ilariucci
authors.forename: Stefano
authors.initials: S
authors.lastname: Luminari
authors.forename: Edi
authors.initials: E
authors.lastname: Viale
authors.forename: Leonhard
authors.initials: L
authors.lastname: Müllauer
authors.forename: Stefania
authors.initials: S
authors.lastname: Dell'Oro
authors.forename: Paolo Giorgio
authors.initials: PG
authors.lastname: Arcidiacono
authors.forename: Maurilio
authors.initials: M
authors.lastname: Ponzoni
authors.forename: Caterina
authors.initials: C
authors.lastname: Patti
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000382:microbiology*; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents